The family that owns Spanish drugmaker Grifols and private equity firm Brookfield are considering whether to take the company private in a deal that could be worth around €5.5 billion (almo
US private equity group Horizon Capital has made an undisclosed investment in marketing technology company Viseven, which serves the pharma and life sciences sectors.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.